BioSpecifics Technologies Corp. is a biopharmaceutical company that is focused on the development of injectable collagenase clostridium histolyticum, which has multiple indications in the United States. The company's XIAFLEX and XIAPEX brands offer treatment for Dupuytren’s contracture and Peyronie’s disease in various countries such as Canada, Australia, Brazil, Mexico, and Europe.